PDL BioPharma Inc (NASDAQ:PDLI)

6.98
Delayed Data
As of Feb 27
 +0.03 / +0.43%
Today’s Change
6.52
Today|||52-Week Range
10.26
-9.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues345.0M362.0M374.5M442.9M
 
 
 
 
 
Depreciation And Amortization330.0K1.4M946.0K5.6M
 
 
 
 
 
 
Operating ExpensesGross Income------437.3M
 
 
General Expenses41.1M16.9M24.5M29.8M
 
 
 
 
 
Total Operating Expenses41.4M18.3M25.5M35.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income303.6M343.7M349.1M407.5M
 
 
 
 
 
Extraordinary Charge-92.5M-766.0K0.000.00
 
 
 
Interest Expense On Debt43.5M36.1M29.0M24.9M
 
 
 
 
 
Other Expenses-17.6M0.00391.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income150.4M307.4M327.1M401.9M
 
 
 
 
 
Income Taxes-58.5M-108.0M-115.5M-137.3M
 
 
 
 
 
Net Income91.9M199.4M211.7M264.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.6M139.7M139.7M139.8M
 
 
 
 
 
Shares To Calculate EPS Diluted178.8M177.4M146.4M159.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.54$1.15$1.45$1.66
 
 
 
 
 
EPS Diluted$0.51$1.15$1.45$1.66
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account